₹1,969.80
+19.95 (+1.02%)
As of 18 Sept 2026, Ipca Laboratories Ltd share price is ₹1,969.80. The stock opened at ₹1,969.80 and had closed at ₹1,949.85 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,252.95 and a high of ₹1,999.00. In terms of performance, Ipca Laboratories Ltd share price has increased by 27.43% over the past six months and has increased by 37.77% over the last year.
IPCALAB Stock Price Chart
Ipca Laboratories Ltd Overview
Market cap₹49,975 Crs
Volume21,176
Prev. Close₹1,949.85
Year range₹1,252.95 - ₹1,999.00
ISININE571A01038
About IPCALAB
Ipca Laboratories is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharmaceutical ingredients (APIs).
Ipca Laboratories Ltd Historical Performance
1 Month Return4.59%
6 Month Return25.68%
3 Year Return112.25%
3 Month Return28.05%
1 Year Return50.16%
5 Year Return63.30%
Ipca Laboratories Ltd Fundamentals
ROCE(TTM)19.04%
P/E Ratio (TTM)40.18
P/B Ratio6.26
Debt to Equity0.04
ROE14.19%
EPS (TTM)49.90
Dividend Yield0.30%
Book Value314.51
Profit Margin16.42%
Operating Margin21.67%
Ipca Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 7,431.39 | 6,749.21 | 6,277.75 | 5,925.81 | 5,491.22 |
| EBITDA | 1,844.51 | 1,314.78 | 1,189.31 | 1,023.04 | 1,291.00 |
| Net Profit | 1,132.52 | 650.76 | 530.41 | 505.70 | 860.37 |
| EPS | 45.84 | 25.65 | 20.91 | 19.93 | 33.91 |
Ipca Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,910.67 |
| Resistance 1 (R1) | 1,985.22 |
| Pivot Point | 1,946.03 |
Ipca Laboratories Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 07-Aug-2026 | 29-May-2026 | 07-Aug-2026 | Final | ₹6.00 |
| 05-Aug-2025 | 29-May-2025 | 05-Aug-2025 | Final | ₹2.00 |
| 27-Nov-2024 | 14-Nov-2024 | 27-Nov-2024 | Interim | ₹2.00 |
| 06-Aug-2024 | 29-May-2024 | 07-Aug-2024 | Final | ₹2.00 |
| 22-Nov-2023 | 10-Nov-2023 | 22-Nov-2023 | Interim | ₹2.00 |
IPCALAB Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Premchand Godha | Chairman & Managing Director |
| A K Jain | Managing Director |
| Pranay Godha | Managing Director & Chief Executive Officer |
Ipca Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Ipca Laboratories Ltd today is ₹1,969.80 on NSE and ₹1,969.80 on BSE.
- The 52-week high of Ipca Laboratories Ltd is ₹1,999.00, while the 52-week low is ₹1,252.95.
- The current market capitalisation of Ipca Laboratories Ltd is approximately ₹49,975 crore.
- The P/E (Price-to-Earnings) ratio of Ipca Laboratories Ltd is 39.80. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Ipca Laboratories Ltd is 5.04. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Ipca Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for IPCALAB on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Ipca Laboratories Ltd has delivered a return of approximately 112.25%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Ipca Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 44.72% promoters, -20.42% FIIs, 37.37% DIIs, and 5.76% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
